Clinical Trial Update: Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of apatinib combined with S-1 for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED